CAS: 61849-14-7; Sodium (Z)-5-((3Ar,4R,5R,6As)-5-Hydroxy-4-((S,E)-3-Hydroxyoct-1-En-1-yl)Hexahydro-2H-Cyclopenta[b]Furan-2-Ylidene)Pentanoate

该化合物是天然的蛋白环酚的一种合成类比,是一种天然的蛋白兰地,主要用作强效血管抑制剂和聚盘抑制剂,在治疗肺动脉高血压和其他心血管条件下具有价值;乙型甲状腺素的特点是能够放松血管光滑肌肉,导致血液流动增加,在肺循环和系统循环中血液压力减少;该物质一般通过静脉注射进行,原因是其短半衰期和溶液不稳定;其化学结构具有多功能组的双环系统,有助于其生物活动;乙型甲状腺素钠也因其快速的代谢作用而著名,主要是肺部,这需要持续注入治疗效果;与任何药物一样,它可能具有副作用,包括低温,冲洗和头头痛,并且需要在管理期间进行仔细监测.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-4760068-A
    优先权日:1982-06-14
    标题:Certain pyridyl alkenoic acid derivatives which inhibit the action of thromboxane A2 synthetase
    发明人:TERAO SHINJI; NISHIKAWA KOHEI
    权利人:TAKEDA CHEMICAL INDUSTRIES LTD
    摘要:Novel compound of the formula: ##STR1## wherein R 1 is pyridyl group, R 2 is a phenyl group, a thienyl group, a furyl group, a naphthyl group, a benzothienyl group or pyridyl group, which may optionally have a lower alkoxy group, a lower alkyl group, a halogen atom, trifluoromethyl group, a lower alkenyl group or methylenedioxy group, R 3 is hydrogen atom or a lower alkyl group, and n is an integer of 0 to 6, Y is sulphur atom, methylene group or a group of the formula: ##STR2## wherein R 4 is hydrogen atom or acetyl group, and m is 0 or 1, and their pharmaceutically acceptable salts having an inhibitory action on bio-synthesis of thromboxane A 2 (TXA 2 ) and an effect of accelerating the productivility of prostaglandin I 2 (PGI 2 ), and can be used for mammals to the prophylaxis or therapy of thrombosis caused by platelet aggregation or ischemic diseases caused by vasospasms in cardiac, cerebral and peripheral circulatory system (e.g. cardiac infarction, apoplexy, infarct of blood vessels in kidney, lung and other organs, pectic ulcer, etc.).

    专利号:US-8658837-B2
    优先权日:2011-08-24
    标 题:Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
    发明人:WEI SHIH-YI; HSU MIN-KUAN; HSU MING-KUN
    权利人:WEI SHIH-YI; HSU MIN-KUAN; HSU MING-KUN; CHIROGATE INT INC
    摘要:Novel processes for preparing optically active cyclopentanones 1 n nwhich are useful for the preparation of benzindene Prostaglandins and novel cyclopentanones are provided. The invention also provides novel processes of preparing benzindene Prostaglandins and novel intermediates for benzindene Prostaglandins.

    专利号:US-4518602-A
    优先权日:1982-10-07
    标题 :Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
    发明人:TERAO SHINJI; NISHIKAWA KOHEI
    权利人:TAKEDA CHEMICAL INDUSTRIES LTD
    摘要:Novel compound of the formula: wherein R1 is a pyridyl group; R2 is a phenyl, thienyl, furyl, naphthyl, benzothienyl or pyridyl group which may have as a substituent a lower alkoxy, a lower alkyl, a halogen, trifluoromethyl, a lower alkenyl or methylenedioxy; R3 is hydrogen, benzyl or a lower alkyl; one of R4 and R5 is hydrogen or a lower alkyl, and the other is an aryloxy, or lower aliphatic hydrocarbon, an alicyclic hydrocarbon having not more than 6 carbon atoms or an aromatic group which may have a substituent, or a group represented by the formula, -S(O)m-R6 (in which R6 is phenyl or a lower alkyl group; m is an integer of 0 to 2), or R4 and R5 each combine with the other to represent one alkylene group; n is an integer of 2 to 6, or a pharmaceutically acceptable salt thereof has a selective inhibitory action on bio-synthesis of thromboxane A2(TXA2) and an effect of enhancing the production of prostaglandin I2(PGI2), and can be used in mammals for to prevention and treatment of arterial thrombosis caused by platelet aggregation or ischemic diseases caused by vasospasms in cardiac, cerebral and peripheral circulatory system (e.g. cardian infarction, apoplexy, infarct of blood vessels in kidney, lung and other organs, pectic ulcer, etc.).

    专利号:US-8183409-B2
    优先权日:2004-05-06
    标题:High yield and rapid synthesis methods for producing metallo-organic salts
    发明人:CHRISTGAU STEPHAN; ANDERSEN JENS E T
    权利人:CHRISTGAU STEPHAN; ANDERSEN JENS E T; OSTEOLOGIX AS
    摘要:A new method for preparing salts of metal cations and organic acids, especially divalent salts of alkaline earth metal ions from group II of the periodic system and carboxylic acids. The method comprising the use of a high temperature (about 90° or more) and, optionally. high pressure, in order to obtain a higher yield, purity and faster reaction speed than obtained with known synthesis methods. In particular, the present invention relates to the production of strontium salts of carboxylic acids. Novel strontium salts are also provided by the present method.

    专利号:US-2013053581-A1
    优先权日:2011-08-24
    标题 :Intermediates for the synthesis of benzindene prostaglandins and preparations thereof

    专利号:JP-6054935-B2
    优先权日:2011-08-24
    标题:Intermediates for the synthesis of benzoindene prostaglandins and their preparation
    浙江奥翔药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ausunpharm.com
    企业联系电话:0576-85589335👤
    📞浙江奥翔药业股份有限公司 ⚠️参考联系方式
    联系人:陶经理
    电话:0576-85589335

    传真:0086-576-85589168
    邮箱:sales@ausunpharm.com
    通信地址: 浙江省化学原料药基地临海园区东海第四大道5号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省化学原料药基地临海园区东海第四大道5号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    台州市科瑞生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharm-intermediates.com
    企业联系电话:0576-88813233👤
    📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
    联系人:金崇光
    电话:0576-88813233
    手机:13396860566
    传真:0576-88813233
    邮箱:sales@pharm-intermediates.com
    通信地址: 台州市开发大道东段288号
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:台州市开发大道东段288号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H. Epoprostenol sodium for treatment of pulmonary arterial hypertension. Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368.
    2: Kiernan FJ, Kluger J, Regnier JC, Rutkowski M, Fieldman A. Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction. Br Heart J. 1986 Nov;56(5):428-32. doi: 10.1136/hrt.56.5.428.
    3: Bandilla D, Goverde M, Giudici P, Lambert O. Microbial challenge test of a novel epoprostenol sodium formulation. Drug Des Devel Ther. 2017 Aug 10;11:2347-2357. doi: 10.2147/DDDT.S140033.

    合成参考文献


    参考文献:10.1007/bf02620735
    摘要:Chan B, Kalabalikis P, Klein N, Heyderman R, Levin M. Assessment of the effect of candidate anti-inflammatory treatments on the interaction between meningococci and inflammatory cells in vitro in a whole blood model. Biotherapy. 1996;9(4):221–8. doi: 10.1007/bf02620735.
    参考文献:10.1007/s001340051027
    摘要:Max M, Kuhlen R, Dembinski R, Rossaint R. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension. Intensive Care Med. 1999 Oct;25(10):1147–54. doi: 10.1007/s001340051027.
    参考文献:10.1007/s11926-002-0029-6
    摘要:Seibold JR. Relaxins: lessons and limitations. Curr Rheumatol Rep. 2002 Aug;4(4):275–6. doi: 10.1007/s11926-002-0029-6.
    参考文献:10.1007/s11897-006-0014-x
    摘要:Craig M, Pereira NL. Right heart catheterization and risk stratification in advanced heart failure. Curr Heart Fail Rep. 2006 Sep;3(3):143–52. doi: 10.1007/s11897-006-0014-x.
    参考文献:10.1007/s00101-006-1072-x
    摘要:Gürtler K, Euchner-Wamser I, Neeser G. [Heparin-induced thrombocytopenia]. Anaesthesist. 2006 Sep;55(9):1009–25; quiz 1026. doi: 10.1007/s00101-006-1072-x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知